Earnings call transcript: EROAD H2 2026 sees stable revenue amid challenges

EROAD reported FY2026 revenue of NZD 195.2 million, roughly flat year over year, but normalized EBIT fell to NZD 2.9 million from NZD 9.9 million as the company increased spending on customer service, platform stability, and transformation. North America remains the main drag, with ARR down 20% and revenue down 7.1%, while New Zealand and Australia were stronger. Management guided to free cash flow positivity and expects Australia to sustain strong mid-digit growth, but shares fell 5% after the update.

Analysis

The market is treating this as a classic quality-vs-growth reset, but the bigger signal is that the business is becoming more country-segmented and therefore more investable on a sum-of-parts basis. Australia is emerging as the near-term torque asset: if the pre-contracted pipeline converts, the step-up in revenue should arrive with better operating leverage than the street is likely modeling, because the incremental spend is largely already in place. New Zealand remains the cash engine, and the key second-order effect is that management is now explicitly using that cash to fund option value rather than defend legacy complexity, which should improve capital allocation optics over the next 2-3 quarters.

North America is the real overhang, but the important nuance is that some churn was low-margin and may actually improve blended economics. That means the path to breakeven is less about growth re-acceleration and more about rightsizing cost-to-serve; if execution holds, the market may have been too punitive on the segment decline because it is removing unprofitable revenue. The risk is that integration drag and transformation spend persist longer than promised, which would keep headline margins depressed even if underlying cash generation stabilizes.

The contrarian point is that the stock may not need a clean macro recovery to rerate; it needs evidence that ANZ can sustain mid-single-digit growth while North America stops consuming management attention. The current setup also creates a hidden call option on AI-driven productivity: if internal automation meaningfully compresses support and product costs, normalized EBIT can inflect faster than consensus expects. That said, the catalyst path is uneven — likely measured in quarters, not days — and investors should expect volatility around any update on CEO appointment, North American cash burn, and the first proof points from Australia conversion.

Key Decisions for Investors

• Go long EROAD on weakness over the next 1-2 weeks, targeting a 3-6 month horizon; risk/reward improves if the market continues to price the business as a single broken story, while ANZ cash flow and Australia conversion are de-risking the downside.
• Pair trade: long EROAD / short a higher-multiple telematics or fleet-software peer with weaker cash conversion, to isolate ANZ execution and margin inflection versus generic SaaS multiple compression.
• Use call spreads rather than outright equity: buy 6-9 month upside calls on EROAD and finance with a higher strike; the thesis is that a modest rerating can occur once North America is clearly less lossy and Australia shows repeatable conversion.
• If trading liquidity permits, fade any rally that is driven purely by AI narrative until the company shows tangible OpEx reduction; the first real catalyst is lower run-rate cost, not AI branding.